Brizy

Brizy2 mg

Levosalbutamol

Eskayef Bangladesh Ltd.

Product Code : 2474
MRP 2.00
10% Off
Best PriceTk
/
1
Section

Alternatives

See All
Product Image
10% Off

Purisal2 mg

Levosalbutamol

Incepta Pharmaceuticals Ltd.

1.80
2.00
Add to cart
Product Image
10% Off

Aire2 mg

Levosalbutamol

Delta Pharma Ltd.

1.53
1.70
Add to cart
Product Image
10% Off

Arolax2 mg

Levosalbutamol

Navana Pharmaceuticals Ltd.

1.53
1.70
Add to cart
Product Image
10% Off

Brodil Levo2 mg

Levosalbutamol

ACI Limited

1.72
1.91
Add to cart
Product Image
10% Off

Comfil2 mg

Levosalbutamol

Pharmasia Limited

1.54
1.71
Out Of Stock
Product Image
10% Off

Lebutal2 mg

Levosalbutamol

Pacific Pharmaceuticals Ltd.

1.71
1.90
Add to cart
Product Image
10% Off

Letol2 mg

Levosalbutamol

Globe Pharmaceuticals Ltd.

1.53
1.70
Add to cart
Product Image
10% Off

Levostar2 mg

Levosalbutamol

Square Pharmaceuticals Ltd.

1.80
2.00
Add to cart
Product Image
10% Off

Purilin2 mg

Levosalbutamol

Opsonin Pharma Ltd.

1.55
1.72
Add to cart
Product Image
10% Off

Respira2 mg

Levosalbutamol

Beximco Pharmaceuticals Ltd.

1.52
1.69
Add to cart
Product Image
10% Off

Salmolin-L2 mg

Levosalbutamol

ACME Laboratories Ltd.

1.53
1.70
Add to cart
Product Image
10% Off

Ventisal-L2 mg

Levosalbutamol

Ibn-Sina Pharmaceuticals Ltd.

1.80
2.00
Add to cart
Section

Medicine overview

Indications of Brizy 2 mg

Brizy 2 mg is indicated for the treatment and prevention of bronchospasm in adults, adolescents & children of 6 years of age and older with reversible obstructive airway diseases.

Theropeutic Class

Short-acting selective & β2-adrenoceptor stimulants

Pharmacology

Brizy 2 mg is a single isomer beta-2 agonist that differs from racemic salbutamol by elimination of (S)-salbutamol. Brizy 2 mg is an effective bronchodilator whose primary mechanism of action is not inhibited by (S)-salbutamol.Thus, when compared with racemic salbutamol, clinically comparable bronchodilation can be achieved. Brizy 2 mg produces bronchodilatation through stimulation of beta-2-adrenergic receptors in bronchial smooth muscles, thereby causing relaxation of bronchial muscle fibres.

Dosage & Administration of Brizy 2 mg

Children (6 -11 years): 5 ml (1 mg), three times daily.Adults and adolescents above 12 years: 5-10 ml (1-2 mg), three times daily.

Interaction of Brizy 2 mg

Other short-acting sympathomimetic bronchodilators or epinephrine should be used with caution with Brizy 2 mg. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.

Contraindications

Brizy 2 mg is contraindicated in patients with a history of hypersensitivity to Brizy 2 mg or any of its components.

Side Effects of Brizy 2 mg

Hypocalcaemia, palpitation, fine tremors of the skeletal muscle and muscle cramps may occur. The other likely side effects are nausea, vomiting, epigastric pain and diarrhoea.

Pregnancy & Lactation

The drug should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus. It is not known whether Brizy 2 mg is excreted in human milk. Caution should be exercised when oral Brizy 2 mg is administered to a nursing woman.

Precautions & Warnings

Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia and by concomitant treatment with xanthine derivatives, steroids and diuretics. Serum potassium levels should be monitored in such situations.

Storage Conditions

Keep in dry place and away from light and heat. Keep out of the reach of children.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.